Our work underscores the utility of suppressing PAN endonuclease activity as a promising anti-influenza strategy, similar design could be used to develop therapeutics that target to other functional domains of the viral polymerase, e.g. cap-binding domain of PB2 subunit50. This evidence concerns the gene ADA2 and influenza.